高光谱成像用于结直肠手术术中肠道灌注定量:精准手术的指导工具
HSI在所有患者中可行,近端肠段StO2值显著高于远端;新辅助放化疗患者StO2也较低。HSI有助于识别临床判断不可靠的边缘灌注段。
要点
- HSI术中评估肠道灌注在所有患者中可行,近端StO2显著高于远端。
- 临床与HSI切缘线不一致患者平均StO2更低(54.55% vs 65.10%)。
- 新辅助放化疗患者StO2较低(51.41% vs 60.51%)。
核心结论
- HSI有助于术中识别临床判断不可靠的边缘灌注肠段。
- 新辅助放化疗患者肠道血供较低,此新发现及HSI灌注定量的临床影响需更大规模试验进一步研究。
研究设计与样本
- 术中使用高光谱成像(TIVITA®)生成组织氧饱和度(StO2)热图。
主要发现
- HSI评估在所有患者中可行,近端肠段StO2值显著高于远端。
- 新辅助放化疗患者StO2较低(51.41 ± 23.41% vs 60.51 ± 24.98%,p = 0.010)。
- 1例患者发生吻合口漏,该患者接受新辅助放化疗及超低位前切除术。
关键数值与推荐
- 临床切缘线与高光谱切缘线不一致> 5 mm时,肠管按高光谱切缘线切除。
- StO2热图用于识别高光谱切缘线。
临床怎么用
- HSI可作为术中肠道灌注定量的辅助工具,帮助确定切除线。
- 对临床判断边缘灌注不可靠的肠段,可考虑使用HSI评估。
- 新辅助放化疗患者肠道灌注较低,术中应更谨慎评估吻合口血供。
局限性
- HSI的临床影响尚需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Poor anastomotic perfusion can cause anastomotic leaks (AL). Hyperspectral imaging (HSI), previously validated experimentally, provides accurate, real-time, contrast-free intestinal perfusion quantification. Clinical experience with HSI is limited. In this study, HSI was used to evaluate bowel perfusion intraoperatively. METHODS: Fifty-two patients undergoing elective colorectal surgeries for neoplasia (n = 40) or diverticular disease (n = 12), were enrolled. Intestinal perfusion was assessed with HSI (TIVITA®, Diaspective Vision, Am Salzhaff, Germany). This device generates a perfusion heat map reflecting the tissue oxygen saturation (StO2) amount. Prior to anastomose creation, the clinical transection line (CTL) was highlighted on the proximal bowel and imaged with HSI. Upon StO2 heat map evaluation, the hyperspectral transection line (HTL) was identified. In case of CTL/HTL discrepancy > 5 mm, the bowel was always resected at the HTL. HSI outcomes were compared to the clinical ones. RESULTS: AL occurred in one patient who underwent neoadjuvant radiochemotherapy and ultralow anterior resection for rectal cancer. HSI assessment was feasible in all patients, and StO2-values were significantly higher at proximal segments than distal ones. Twenty-six patients showed CTL/HTL discrepancy, and these patients had a lower mean StO2 (54.55 ± 21.30%) than patients without discrepancy (65.10 ± 21.30%, p = 0.000). Patients undergoing neoadjuvant radiochemotherapy showed a lower StO2 (51.41 ± 23.41%) than non-neoadjuvated patients (60.51 ± 24.98%, p = 0.010). CONCLUSION: HSI is useful in detecting intraoperatively marginally perfused segments, for which the clinical appreciation is unreliable. Intestinal vascular supply is lower in patients undergoing neoadjuvant radiochemotherapy, and this novel finding together with the clinical impact of HSI perfusion quantification deserves further investigation in larger trials.
引用
- Barberio M, Lapergola A, Benedicenti S, et al. Intraoperative bowel perfusion quantification with hyperspectral imaging: a guidance tool for precision colorectal surgery. Surg Endosc. 2022. PMID: 35836033. doi:10.1007/s00464-022-09407-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。